154 Parenteral Deep Vein Thrombosis (DVT) Prophylaxis Refusal
Introduction: The American Society of Hematology recommends that patients with acceptable bleeding risk receive deep vein thrombosis (DVT) prophylaxis during their hospital stay. A study at Cone Health found that 11% of parenteral DVT prophylaxis doses were missed, primarily due to patient refusal (73.42%). This retrospective study evaluated changes in refusal rates after implementing clinical monitoring software alerts for pharmacists about DVT prophylaxis refusals.
Authors
- Melissa Maccia
- Shimaa Abdel Salam (ORCID: https://orcid.org/0000-0002-9825-5233)
- J. B. Groce
Institutions
- Cone Health (US)
- Campbell University (US)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.102808
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00